Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.
The Massachusetts district court awarded Insulet a total of $452 million, including $170 million in compensation plus $282 ...
Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on ...
The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create ...
A federal jury on Tuesday awarded Insulet $452 million in its patent skirmish with EOFlow over insulin patch pumps. The jury awarded Insulet $170 million in compensatory damages from EOFlow and an ...
Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...
Insulet, an Acton medical device manufacturer, has been awarded $452 million in total damages by a federal jury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback